Precision Biosciences Inc (DTIL)

May 17, 2026

Precision BioSciences stock (US74019P1084): gene-editing player updates clinical pipeline and strate - AD HOC NEWS

May 17, 2026

May 16, 2026

Number of shareholders of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView

May 16, 2026

May 15, 2026

DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

May 15, 2026

May 14, 2026

Precision BioSciences (DTIL) Highlights Promising Data in DMD Tr - GuruFocus

May 14, 2026

May 14, 2026

Precision Biosciences Presents New Preclinical Data Supporting Advancement of Pbgene-Dmd into Clinic - marketscreener.com

May 14, 2026

May 14, 2026

Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Cl - PharmiWeb.com

May 14, 2026

May 14, 2026

Precision BioSciences (DTIL) Highlights Promising Data in DMD Treatment - GuruFocus

May 14, 2026

May 14, 2026

Precision BioSciences presents DMD gene therapy preclinical data - Investing.com

May 14, 2026

May 14, 2026

Precision BioSciences presents DMD gene therapy preclinical data By Investing.com - Investing.com Canada

May 14, 2026

May 14, 2026

Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting - Business Wire

May 14, 2026

May 13, 2026

Analyst Forecasts For Precision BioSciences, Inc. (NASDAQ:DTIL) Are Surging Higher - simplywall.st

May 13, 2026

May 13, 2026

Bullish: Analysts Just Made A Notable Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts - Yahoo Finance

May 13, 2026

May 12, 2026

Precision BioSciences stock (US74019P1084): Q3 2024 earnings report shows EPS loss - AD HOC NEWS

May 12, 2026

May 11, 2026

Precision BioSciences exits substantial shareholder role in Imugene - TipRanks

May 11, 2026

May 10, 2026

DTIL SEC FilingsPrecision Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan

May 10, 2026

May 07, 2026

Precision BioSciences (DTIL) reports Q1 loss, tops revenue estimates - MSN

May 07, 2026

May 07, 2026

Analysts’ Top Healthcare Picks: Precision BioSciences (DTIL), Nuvectis Pharma (NVCT) - The Globe and Mail

May 07, 2026

May 07, 2026

Guggenheim Initiates Precision BioSciences(DTIL.US) With Buy Rating, Announces Target Price $19 - Moomoo

May 07, 2026

May 06, 2026

H.C. Wainwright Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $60 - Moomoo

May 06, 2026

May 06, 2026

Precision BioSciences Q1 2026 earnings preview - MSN

May 06, 2026

May 05, 2026

Precision BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 05, 2026

May 05, 2026

MSN Money - MSN

May 05, 2026

May 05, 2026

DTIL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

May 05, 2026

May 05, 2026

Precision BioSciences reports Q1 EPS (75c) vs. ($2.21) last year - TipRanks

May 05, 2026

May 05, 2026

Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 05, 2026

May 05, 2026

Precision BioSciences (DTIL) Q1 2026 loss narrows as gene-editing pipeline advances - Stock Titan

May 05, 2026

May 05, 2026

Precision BioSciences 1Q 2026: Revenue $10.8M, EPS $(0.75) — 10-Q Summary - TradingView

May 05, 2026

May 05, 2026

Precision BioSciences (DTIL) posts Q1 2026 results and advances HBV and DMD gene editing - Stock Titan

May 05, 2026

May 05, 2026

DTIL: Advanced gene editing trials and improved financials, with strong cash runway through 2028 - TradingView

May 05, 2026

May 05, 2026

Precision BioSciences: Q1 Earnings Snapshot - marketscreener.com

May 05, 2026

May 05, 2026

BRIEF-Precision BioSciences, Inc. Q1 Revenue USD 10.838 Million Vs. IBES Estimate USD 4.05 Million - TradingView

May 05, 2026

May 05, 2026

Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance

May 05, 2026

May 04, 2026

Precision BioSciences (DTIL) Set to Report Q1 2026 Earnings with Analyst Expectations - GuruFocus

May 04, 2026

May 02, 2026

Precision BioSciences (DTIL) Projected to Post Earnings on Tuesday - MarketBeat

May 02, 2026

May 01, 2026

Precision BioSciences Inc expected to post a loss of 65 cents a shareEarnings Preview - TradingView

May 01, 2026

Apr 30, 2026

Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026 - BioSpace

Apr 30, 2026

Apr 30, 2026

Press Release: Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026 - Moomoo

Apr 30, 2026

Apr 30, 2026

H.C. Wainwright Reaffirms Their Buy Rating on Precision BioSciences (DTIL) - The Globe and Mail

Apr 30, 2026

Apr 29, 2026

Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD Study - BioSpace

Apr 29, 2026

Apr 29, 2026

Precision BioSciences (DTIL) Launches First Clinical Trial for P - GuruFocus

Apr 29, 2026

Apr 29, 2026

Precision BioSciences opens enrollment for DMD gene therapy trial By Investing.com - Investing.com South Africa

Apr 29, 2026

Apr 29, 2026

Precision BioSciences opens enrollment for DMD gene therapy trial - Investing.com

Apr 29, 2026